AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 194 filers reported holding AURINIA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4 | -20.0% | 528 | 0.0% | 0.00% | – |
Q2 2023 | $5 | -16.7% | 528 | 0.0% | 0.00% | – |
Q1 2023 | $6 | +200.0% | 528 | 0.0% | 0.00% | – |
Q4 2022 | $2 | -100.0% | 528 | 0.0% | 0.00% | – |
Q3 2022 | $4,000 | -20.0% | 528 | 0.0% | 0.00% | – |
Q2 2022 | $5,000 | 0.0% | 528 | +39.7% | 0.00% | – |
Q1 2022 | $5,000 | -44.4% | 378 | 0.0% | 0.00% | – |
Q4 2021 | $9,000 | -10.0% | 378 | -14.1% | 0.00% | – |
Q3 2021 | $10,000 | +233.3% | 440 | +84.9% | 0.00% | – |
Q2 2021 | $3,000 | 0.0% | 238 | 0.0% | 0.00% | – |
Q1 2021 | $3,000 | 0.0% | 238 | 0.0% | 0.00% | – |
Q4 2020 | $3,000 | -66.7% | 238 | -62.9% | 0.00% | – |
Q3 2020 | $9,000 | 0.0% | 642 | +7.7% | 0.00% | – |
Q2 2020 | $9,000 | 0.0% | 596 | 0.0% | 0.00% | – |
Q1 2020 | $9,000 | -18.2% | 596 | +12.0% | 0.00% | – |
Q4 2019 | $11,000 | +266.7% | 532 | -7.8% | 0.00% | – |
Q3 2019 | $3,000 | -25.0% | 577 | 0.0% | 0.00% | – |
Q2 2019 | $4,000 | +33.3% | 577 | +24.4% | 0.00% | – |
Q1 2019 | $3,000 | 0.0% | 464 | 0.0% | 0.00% | – |
Q4 2018 | $3,000 | 0.0% | 464 | 0.0% | 0.00% | – |
Q3 2018 | $3,000 | 0.0% | 464 | 0.0% | 0.00% | – |
Q2 2018 | $3,000 | +50.0% | 464 | 0.0% | 0.00% | – |
Q1 2018 | $2,000 | – | 464 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blackcrane Capital, LLC | 111,608 | $2,470,000 | 3.15% |
ACT CAPITAL MANAGEMENT, LLC | 180,000 | $3,983,000 | 2.06% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 167,889 | $3,715,000 | 1.92% |
DG Capital Management, LLC | 402,200 | $8,901,000 | 1.81% |
NEA Management Company, LLC | 5,172,683 | $114,471,000 | 1.36% |
KESTRA PRIVATE WEALTH SERVICES, LLC | 801,100 | $17,728,000 | 0.99% |
Altium Capital Management LP | 144,000 | $3,187,000 | 0.84% |
HighMark Wealth Management LLC | 50,569 | $1,119,000 | 0.82% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 123,500 | $2,724,000 | 0.66% |
SEVEN EIGHT CAPITAL, LP | 288,840 | $6,392,000 | 0.62% |